Pairwise meta-analyses of SGLT2i CVOTs verified that SGLT2i reduced MACE, HHF and a composite kidney outcome in the overall population vs placebo [142, 249]
"Done responsibly, I think the labels could actually help people make smart choices while they're on therapies, but done poorly, it could trivialize the medical treatment and drift into diet culture marketing," Christen said
For diabetes treatment context, the American Diabetes Association Standards of Care outline evidence-based approaches to type 2 diabetes management
Bibcode:2012MolPE..65..562Z
Eli Lilly, the maker of Zepbound and Mounjaro, had pushed back against the OFAs assertion that shortages of tirzepatide were still in place, and has also claimed that versions of the drug made by compounded pharmacies are often untested, unapproved knockoffs, according to NBC News